These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7405982)

  • 1. Improvement in artificial second-trimester abortion with a new tissue-selective prostaglandin E2 derivative.
    Schmidt-Gollwitzer R; Schuessler B; Elger W; Schmidt-Gollwitzer M
    Am J Obstet Gynecol; 1980 Aug; 137(7):867-8. PubMed ID: 7405982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abortion with sulprostone, a prostaglandin E2 derivative.
    Pulkkinen MO; Kajanoja P; Kivikoski A; Saastamoinen J; Selander K; Tuimala R
    Int J Gynaecol Obstet; 1980; 18(1):40-3. PubMed ID: 6106599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First and midtrimester abortion with intramuscular injections of sulprostone.
    Ballard CA
    Contraception; 1981 Aug; 24(2):145-50. PubMed ID: 7297066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and acceptability of intravenously administered sulprostone, a tissue-selective prostaglandin-E2 derivative, for induction of first-trimester abortion.
    Schuessler B; Schmidt-Gollwitzer K; Hoebich D; Schmidt-Gollwitzer M
    Contraception; 1979 Jan; 19(1):29-38. PubMed ID: 428222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
    Ballard CA
    Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
    Heinzl S; Winkler C
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine motility and cervical ripening in second trimester elective abortion by two different PGE analogues.
    Di Lieto A; Catalano D; Albano G; Uccello N; Civetta A; Ferrara R; Fimiani R; Pontillo M; Paladini A
    Clin Exp Obstet Gynecol; 1991; 18(4):251-9. PubMed ID: 1790608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality.
    Kanhai HH; Keirse MJ
    Prenat Diagn; 1993 Feb; 13(2):117-21. PubMed ID: 8464832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
    Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J
    Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of second trimester pregnancy with intraamniotic administration of 16-phenoxy-omega-tetranor-PgE2-methylsulfonamide (SHB 286) alone and combined with oxytocin and calcium gluconate.
    van den Bergh AS; Haspels AA
    Contraception; 1978 Dec; 18(6):635-9. PubMed ID: 750189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sulprostone for second trimester abortions and its effects on liver and kidney function.
    Ranjan V; Hingorani V; Kinra G; Agarwal N; Pande Y
    Contraception; 1982 Feb; 25(2):175-84. PubMed ID: 7075190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological action and half life in plasma or intramuscular sulprostone for termination of second trimester pregnancy.
    Briel RC; Lippert TH
    Prostaglandins Med; 1981 Jan; 6(1):1-8. PubMed ID: 7220653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.